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Abstract
Oral administration of 17α-methyltestosterone (MT) was used to induce masculinization of sexually undifferentiated 
muskellunge, Esox masquinongy. Three groups of muskellunge (mean weight, 2.5 ± 0.6 g) were submitted to MT treatment 
(15 mg of MT/kg) for 60 days. An additional one group was used as a control (hormone-free diet). Food was distributed over 
a 10-h period by using automatic belt feeders. Blood was sampled in both control and treated fish at different intervals during
and after feeding: before (0 h), at 3 h, 6 h, and cessation of feeding (10 h), and after a fast of 22 h (32 h). MT had no
significant effect on growth and survival in muskellunge 6 months after the treatment. Concentrations of plasma MT
increased during the feeding period and reached their maximum levels 6 or 10 h after starting feeding. This rapid increase of
MT indicated a rapid absorption of this steroid. Plasma MT levels then declined and reached a radir by 22 h after cessation of
feeding, suggesting that MT is rapidly metabolized and excreted. The profiles of plasma testosterone during the MT
treatment did not differ significantly between control and MT-treated groups. During and after the MT treatment, the 
concentration of plasma testosterone did not differ significantly between control and MT-treated groups. Moreover, no sexual 
dimorphism of testosterone levels was observed. Six months after treatment, the sex ratio in MT-treated groups (33% males, 
62% females, and 5% intersex) was opposite to control (70% and 30%, respectively) and differed significantly. This suggests
that at 15 mg of MT/kg over 60 days, a paradoxical feminization took place. 
1. Introduction 
Muskellunge, Esox masquinongy, is a very popular sport fish in central North America. The 
sport fishery for this species in many states relies on annual artificial propagation and stocking of 
fingerlings to maintain the population because of the failure of natural reproduction in reservoirs [1]. 
Like many economically important cool-water species, muskellunge exhibit sexual dimorphic growth 
where females grow significantly faster and larger than males. Thus, the development of methods to 
produce all-female populations of muskellunge will lead toward the production of trophy fish for sport 
fisherman and will attract interest for commercial aquaculture. 
The synthetic steroid 17α-methyltestosterone (MT) is a male-specific hormone commonly used 
to induce sex reversal in teleost fish [2]. However, the effect of MT is dependent on various factors such 
as dose, timing and duration of treatment, and mode of administration [3]. MT was successfully used to 
masculinize genetic and gynogenetic females into phenotypic males [4-9]. Thus, if the female
muskellunge is homogametic (XX), such sex reversal would provide homogametic males (neomales)
whose offspring would be 100% females. 
The uptake and the depletion of MT have been reported in several species such as coho salmon 
Oncorhynchus kisutch [10], rainbow trout Oncorhynchus mykiss [11-13], and cichlids Oreochromis 
mossambicus [11], Oreochromis aureus [14,15], and Oreochromis niloticus [16]. Based on the results of 
experiments with radiolabeled hormone, it was inferred that MT is rapidly metabolized, and excreted. 
To our knowledge, there are no published reports on direct measurement of MT in fish blood plasma. 
The primary aim of the present investigation was to provide such data by determining the uptake and the 
depletion of MT in blood plasma of muskellunge fed MT-enriched food. 
  
 
 
 
 
 
 
 
 
Androgens have been reported to be involved in sex determination in salmonid fish [17, 18]. 
However, dietary treatment with MT can inhibit in vitro testosterone production in rainbow trout [18]. 
Consequently, we also examined changes in blood plasma testosterone during and after the MT
treatment. Moreover, we described the effects of MT treatment on the growth, survival, and sex ratio of 
muskellunge. 
Fig. 1. Sampling procedure.
2. Materials and methods 
Juveniles of mixed-sex muskellunge (n = 800; mean weight, 2.5 ± 0.6 g; mean length, 98 ± 7.5 
mm), reared at Ohio’s Kincaid State Fish Hatchery, were moved to the Columbus aquaculture 
laboratory. Fish were fed initially with freshly hatched Artemia salina nauplii and then weaned to 
artificial diet (Zeigler Brothers, Gardners, PA, USA). Fish were assigned randomly into four tanks (200 
fish per tank); i.e. one tank was used as a control (hormone-free diet) and three tanks were fed MT-
enriched food for 60 days. Each circular tank was supplied with continuously aerated running freshwater 
(60 l/h). Fish were maintained in ambient water temperature (6-21°C) and under a constant light regime
of 12-h light: 12-h dark. 
MT (Sigma, St. Louis, MO, USA) was dissolved in ethyl alcohol and incorporated into a
commercial dry diet (New York diet 4, Zeigler Brothers) at a dose level of 0 (control diet) or 15 mg of 
MT/kg of food. The ethyl alcohol was allowed to completely evaporate at room temperature and the 
diets were stored at -4°C. The food was distributed by using automatic belt feeders over a 10-h period at 
a rate of 10% total tank biomass during the first 10 days and 5% thereafter. After the MT treatment (Day 
60), rations were adjusted daily depending on the amount of food remaining on the tank bottom the next 
morning. Feeding rate averaged 5% to 10% biomass daily. Tanks were cleaned and the food residues
discarded daily. 
To monitor the effects of hormonal treatment on sexual differentiation, representative fish 
samples were obtained from each tank at different periods (Fig. 1). Fish were anesthetized with MS-222 
(50 mg/l), individually weighed (± 0.1 g), and measured (total length to 1 mm). The head, tail, and 
viscera from each fish were removed before fixation in Bouin’s solution. The vertebrae and a portion of 
the muscle tissue were removed before dehydration and embedding in paraffin. Cross-sections were cut 
at 7 µm, stained with Mayer’s hematoxylin and eosin, examined, and documented by using an Olympus
photographer microscope (Olympus, New Hyde Park, NY, USA). 
To determine the uptake and kinetics of MT in the fish, blood samples were collected in control 
and treated fish at the following different intervals of feeding: on Day 55 before (0 h) and at the end of 
  
 
 
 
 
 
 
 
 
 
 
feeding (10 h), on Day 56 after 3 h and 6 h of feeding, and on Day 57 after a fast of 22 h (32 h) (Fig. 1). 
Testosterone plasma levels were determined for the samples used for MT (during MT treatment) and on 
Day 250 (6 months after cessation of MT treatment). Blood samples were taken from the caudal vessel 
by using a heparinized needle and syringe. The samples were kept on crushed ice until centrifugation at 
1500 × g for 10 min, after which plasma was removed, frozen, and stored at -20°C until 
radioimmunoassay (RIA). Plasma levels of MT were measured by using a commercially available RIA 
kit (Laboratoire d’Hormonologie, Marloie, Belgium) and the plasma levels of testosterone (T) were 
determined by RIA according to methods similar to those of Ottobre et al. [19]. In both cases, the 
steroids were previously extracted with ethyl ether. Standard and radiolabeled T were obtained from 
ICN Pharmaceutical (Costa Mesa, CA, USA) and NEN (Boston, MA, USA), respectively. The T 
antiserum was provided by the Institute of Animal Physiology (University of Agriculture and 
Technology, Olsztyn, Poland) and the characteristics of this antiserum have been reported previously by 
Dabrowski et al. [20]. Both assays were validated for use with muskellunge plasma (Table 1). 
Table 1 
Radioimmunoassay characteristics of steroid hormones in muskellunge 
The MT antiserum cross-reacted with testosterone (12.6%), with dihydrotestosterone (2.8%), and 
also with some metabolites of MT identified by Cravedi et al. [13] such as 17α-methyl-5β-androstan­
17β-ol-3-one (48%) and 17α-methyl-5α-androstan-3-17β-diol (12.6%). According to the RIA for MT, 
the concentration of MT in the plasma of fish not supplemented with MT was negligible. As such, cross-
reactivities with circulating androgens is thought to have little impact on our estimates of MT 
concentrations. 
The cross-reactivity of T antiserum at 50% binding was determined to be 6.7% with MT. 
Because levels of MT in MT-treated fish are often quite high, this level of cross-reactivity could
confound estimates of plasma testosterone. Thus, it was necessary to correct the values of T obtained for 
the concentrations of MT present in each sample. Separate standard curves were developed by using the
T antiserum and increasing doses of T and MT. The equations representing these standard curves were 
then determined. 
T: y = 3.335 - [0.9774 × log(T)] 
MT: y = 4.5789 - [0.8041 × log(MT)] 
These equations were solved simultaneously by subtraction in the following manner: 
3.335 - [0.9774 × log(T)] = 4.5789 - [0.8041 × log(MT)] 
log(T) = ( -1.2439 + [0.8041 × log(MT)])/0.9774 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T = antilog{( -1.2439 + [0.8041 × log(MT)])/0.9774} 
By substituting the previously determined concentration of MT for each sample into this equation, it was 
possible to determine the amount that MT contributed to each estimate of T. This amount was then 
subtracted from each estimate of T to obtain the final value. A similar strategy for accounting for cross-
reactivity of a prostaglandin RIA was used by Silvia et al. [21]. 
Results are expressed as mean ± SD or SE values. Weight, length, MT, and T concentrations 
were first analyzed by one-way analysis of variance for changes that might have occurred during the 
experimental period. Then, each parameter was compared simultaneously among all treatments by using 
two-way analysis of variance to test for treatment effects. The x2 test was used for analysis of alterations
in sex ratios. Intersex fish were combined with females in the groups treated with 17α­
methyltestosterone so that only fish that were completely sex-reversed were recognized in the x2 test as 
having been affected by the treatment. Homogeneity of variance was confirmed for all data before
analysis. 
3. Results 
3.1 Growth and survival 
On Day 44 (September), we found that one MT-treated group (MT-2) grew more slowly (P < 
0.01) than the other groups (control and MT-1 and MT-3) (Fig. 2). Higher mortality than in other groups
was also recorded in MT-2 (17% vs. 11%). The cause of this differences in survival was not identified.
Fifty-five days after the treatment ended (Day 115, November), the weights and lengths of the fish from
the MT-treated groups did not differ significantly (P > 0.05) from those of the control group (Fig. 2). 
However, a significant difference (P < 0.01) was observed between two MT-treated groups (MT-1 and 
MT-2). These differences disappeared 6 months after cessation of treatment (Day 250, March), when no 
significant differences (P > 0.05) in size between the different groups were found (Fig. 2). At the end of 
the experiment (Day 250, March), specific growth rate was similar in all groups averaging 1.03 ±
0.02%/day (Table 2). After some mortality before Day 44 in Group MT-2, survival of muskellunge was 
high in all groups. 
3.2 Uptake and depletion of MT 
In two MT-treated groups (MT-1 and MT-2), concentrations of MT in blood plasma increased 
during the feeding and reached their maximum levels 10 h after onset of feeding (Fig. 3). At 32 h after 
the onset of feeding (22 h after cessation of feeding), concentrations of MT in those two groups declined 
significantly (P < 0.01) and were similar to those observed before feeding. In the third MT-treated group 
(MT-3), the profile of blood plasma MT was different and the maximum level of MT was observed 6 h 
after feeding. The presence of MT in the plasma of the control group (< 1 ng/ml) may be explained by 
the cross-reactivity of the MT antibody with T (12.6%) and dihydrotestosterone (2.8%) (Fig. 4). 
3.3 Sex ratio 
Fish from the three MT-treated groups were combined for the analysis of sex ratio, because no 
significant difference was observed between the three tanks treated with MT. Histological examinations 
of gonad cross-sections before MT treatment revealed that 65% of fish had undifferentiated gonads and 
35% were females (Table 3; Fig. 5A and B). During the treatment (Day 44), the sex ratio in control and 
MT-treated groups was close to 1:1. In the MT-treated group, however, the male gonads consisted 
  
 
 
    
   
mainly of vacuolized connective tissue (Fig. 5C). Fifty-five days after treatment (Day 115, November), 
the percentage of females in the MT-treated group declined whereas the percentage of intersex fish (with 
presence of testicular and ovarian tissues) increased (Fig. 5D and F). Six months after the treatment
(Day 250, March), the percentages of females and males in the control group were similar to those 
observed before the treatment, assuming that all undifferentiated gonads become testes in fish of this 
size ([32]; Table 3; Fig. 5A and E). The sex ratio of the MT-treated group (62:33, females/males) was 
opposite to the control group (30:70) and this difference was significant. 
Fig. 2. Effects of oral administration of 17α-methyltestosterone (MT) for 60 days on the weight (A) and length (B) of
muskellunge in control and MT-treated groups. Data are presented as mean ± SD values (n = at least 10 per time point). Error 
bars ≤ the data point symbols are not shown.
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
Fig. 3. Changes in blood plasma 17α-methyltestosterone (MT) in control and MT-treated groups. Data are presented as mean
± SEM values (n = 4 or 5 per time point, for treated and control groups, respectively) and are standardized to the onset of
feeding MT (time 0; i.e. 9 h on Fig. 1). Error bars ≤ the data point symbols are not shown.
3.4. Blood plasma testosterone levels 
The profiles of plasma T during the MT treatment (Days 55-57, September) did not differ
significantly between control and MT-treated groups (P > 0.05) (Fig. 4). Although between Days 55 and 
57 the concentrations of plasma T were twice as high as in MT-treated groups in comparison with the 
control group (Table 4), great variation among individual fish resulted in no significant difference. Six 
months after the MT treatment (Day 250, March), the levels of plasma T were significantly (P < 0.05) 
lower than those between Days 55 and 77 (Table 4). 
Table 2 
Effect of oral administration of MT for 60 days on specific growth rate (SGR) and survival rate of muskellunge 
    
 
 
 
 
 
 
 
 
 
  
 
Table 3 

Effect of oral administration of MT for 60 days on sex ratio of muskellunge (% of analyzed fish) 

4. Discussion
Differences in growth and 17α-methyltestosterone plasma concentrations were observed between 
three MT-treated replicates (Figs. 2 and 3). Those variations might be explained by the feeding behavior
and territoriality of the muskellunge. This species is an active predator, and therefore, individual
variability in the acceptability of the dry diet is an expected result. The use of belt feeders provides a 
continuous food supply for the muskellunge during the feeding period, which is necessary because 
muskellunge will not pick up pellets on the bottom of the tank. As reported by Casselman [22], Northern 
pike (Esox lucius), another esocid fish fed ad libitum with minnows, also have shown individual 
variation in feeding rate. Moreover, a direct correlation existed between the rate of food consumption 
and swimming activity. The establishment of hierarchies in feeding among the fish and the number of 
dominant muskellunge within each tank might also reflect the variability of dry food intake among the 
three MT-treated groups. These factors could not be controlled and reflect specificity of the species. 
Fig. 4. Changes in blood plasma testosterone (T) in control and 17α-methyltestosterone (MT)-treated groups. Data are 
presented as mean ± SEM values (n = 4 or 5 per time point, for treated and control groups, respectively) and are standardized 
to the onset of feeding MT (time 0; i.e. 9 h on Fig. 1). Error bars ≤ the data point symbols are not shown.
  
 
 
 
 
 
 
 
 
    
 
 
 
 
   
 
The anabolic effects of MT on growth have been reported in several teleost fish such as common 
carp Cyprinus carpio [23,24], coho salmon [10], rainbow trout [25], and cichlids [26,27]. However, the 
magnitude of the response to MT depends on many factors including age, size, developmental stage, 
temperature, salinity, dietary factors, treatment duration, season, and method of application [28]. 
Kuwaye et al. [26] also emphasized that, in some cases, it has remains unclear as to whether MT affects 
growth directly or through its ability to reverse sex. However, our study clearly showed that, in 
muskellunge, oral administration of MT at a dose of 15 mg/kg of food did not significantly increase the 
growth during or after the MT treatment. Specific growth rates of control and hormone-treated groups
were similar (Table 2) and comparable with those obtained by Brecka et al. [29] where muskellunge was 
fed semipurified diets containing 37% or 40% protein (specific growth rate, 0.98% and 1.18%/day, 
respectively). Although treatment with a synthetic steroid induces, in general, higher mortality than in
control [30], the survival rate of muskellunge was not affected by the MT treatment. 
The changes of blood plasma MT in muskellunge are consistent with the findings in salmonids, 
ictalurids, and cichlids fishes [10-12,14-16]. The appearance of MT in the circulation of muskellunge 
within 3 to 6 h indicates a rapid absorption of the steroid. Diminished intake may accelerate peak of MT 
in blood (Fig. 2). Then, plasma MT levels declined and reached a nadir by 22 h after cessation of 
feeding. In blue tilapia fed a single meal of diet containing 30 µg of radiolabeled MT, Goudie et al. [15] 
observed that the radioactivity was the highest in all tissues 6 to 12 h after the feeding. Radioactivity 
declined nearly 90% by 4 days and only 0.5% of original radioactivity remained after 21 days. In coho-
salmon-fed [3H]MT, maximum uptake in blood and nonexcretory tissues was reached between 2 and 8 h 
after feeding. Then, after 10 days of feeding the hormone-free diet, the concentration of radioactive
substances was reduced to < 2 ng/g in all tissues [10]. Thus, it appeared that the direct measurement of
MT allowed us to show that this androgen is rapidly metabolized in muskellunge. The excretion of MT 
occurred primarily as free metabolites in water and as glucuronide conjugates in feces [12]. Moreover,
the minor importance of urinary excretion in fish may be related to preferential elimination across the
gill and to the significant role played by the bile in steroid metabolism. Cravedi et al. [12] reported that
in rainbow trout ≈20% of the ingested radiolabeled MT was eliminated in the gallbladder at 72 h. This 
elimination occurred after biotransformation of the parent compounds into conjugated metabolites, 
probably in the liver. 
Table 4 
Levels of plasma testosterone (pg/ml) in muskellunge during (Days 55 to 57) and after (Day 250) MT treatment in control 
and MT-treated groups 
Data are mean ± SE values. Mean values with the same superscript designation are not significantly different from each other
(P > 0.05). MT, 17α-methyltestosterone. 
 
 
 
  
  
 
 
 
 
 
 
Fig. 5. Cross-sections of muskellunge gonads. (A) Undifferentiated gonad connected to the dorsal wall from a fish sampled 
before 17α-methyltestosterone (MT) treatment (×300). (B) Ovary from a fish sampled before MT treatment (×300). Note the 
presence of the ovarian sac (os) and lobules containing individual primary oogonia (arrows). (C) Testis consisted mainly of
vacuolized tissue (v) from a fish during MT treatment (×300). (D) Intersex gonad from a fish during the MT treatment with 
presence of ovarian sac (os), oocytes (o), and spermatogenic tissue (arrow) (×300). (E) Testis containing spermatogenic 
tissues (arrows) from a fish after MT treatment (×300). (F) Ovary with primary oocytes (arrows) containing nucleus (n) from
a fish after MT treatment (×300). 
Yamamoto [31] reported that complete and functional sex reversal should occur if the
administration of sex hormones is started at the undifferentiated gonad stage and is continued through 
the subsequent stages of sexual differentiation. In muskellunge, the anatomical differentiation of the 
female gonad occurs when fish size ranges between 119 and 151 mm and precedes the one of the male
(192 to 229 mm) [32]. The size of muskellunge at the beginning of this experiment was 98 mm, and 
histological examination before the experiment revealed that some fish were already differentiated as 
females. During the MT treatment, the sex ratio of the MT-treated groups was similar to the control 
group. However, in the MT-treated groups, the male gonads consisted mainly of vacuolized connective
tissues. In sea bream, Dicentrarchus labrax, gonads of this type have been classified by Blasquez et al. 
[33] as partially sterile gonads. The appearance of partially sterile fish denotes inhibitory effects of MT 
on gonadogenesis after prolonged treatment [33,34]. These inhibitory effects of MT were confirmed by 
an increase in the percentage of fish with intersex gonads 2 months after the treatment began and also by 
a change in the sex ratio to 62:32:5 (female/male/intersex) 6 months after the treatment. Thus, oral 
administration of MT at a dose of 15 mg/kg food for 60 days induced paradoxical feminization in 
muskellunge. This phenomenon, previously reported in the African catfish Clarias gariepinus [35], 
channel catfish Ictalarus punctatus [36], rainbow trout [37], coho salmon [38], and cichlid O.
mossambicus [39], results either from a high dose of androgens or from a prolonged period of androgen 
treatment. Piferrer and Donaldson [38] suggested that paradoxical feminization may be due more to 
aromatization than to inhibition of in vivo synthesis of androgens. However, these authors also stressed 
  
 
 
 
 
 
 
  
     
  
    
  
 
 
 
   
  
 
  
 
   
  
  
  
  
    
that in some species, aromatization and inhibition of in vivo synthesis of androgens could be the
causative factor. Thus, the use of nonaromatizable androgens in the diet such as 17α­
methyldihydrotestosterone may result in masculinization rather than feminization of fish.
The presence of high concentrations of T in the plasma of control and MT-treated fish during the 
MT treatment indicated the steroidogenic capabilities of muskellunge juveniles undergoing sex 
differentiation [32]. However, no sexual dimorphism of plasma T levels were found during or after the 
MT treatment (Table 4). As reported in several teleost fish [40-42] and in mammals [43], T production 
is possible only after the onset of gonadal differentiation. In muskellunge, this event did not occur 
shortly after hatching, as reported by Fitzpatrick et al. [44] in coho salmon, but later when the fish size
ranged between 90 and 151 mm. In contrast to the rainbow trout in which the production of gonadal 
steroid was inhibited by the MT treatment [18], the levels of plasma T in muskellunge did not seem to 
be affected by the MT treatment because no significant difference was found between control and MT-
treated groups. Nevertheless, future studies must clarify the involvement of the endocrine system in the 
process of sexual differentiation in muskellunge by determining the profiles of sex steroids 
(testosterone, estradiol-17β, and 11-ketotestosterone) through the period of sexual differentiation and by 
correlating these levels with gonadal development. 
In summary, we presented actual concentration of MT in fish blood and addressed the question 
of direct impact of synthetic steroid on production of T in juvenile differentiating fish. The dose of MT, 
commonly regarded as low to cause sex reversal in fish, resulted in vacuolization of testes, and possibly 
in paradoxical feminization in muskellunge. It may also be concluded that a dietary supplementation of
synthetic androgen, because of a variable intake of individual fish, may result in the profoundly different 
response, and other means of treatment need to be explored. 
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